Eosinophilia is associated with a higher mortality rate among patients with autoimmune lymphoproliferative syndrome

American Journal of Hematology

Volumn 82, Issue 7, 2007, Pages 615-624

  Kim, Yae Jean ^a,c   Dale, Janet K ^a   Noel, Pierre ^b   Brown, Margaret R ^b   Nutman, Thomas B ^a   Straus, Stephen E ^a   Klion, Amy D ^a,d  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c Sungkyunkwan University   (South Korea)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

ALPS; Apoptosis; Autoimmunity; Eosinophil; Lymphadenopathy

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN E; INTERLEUKIN 5;

AUTOIMMUNITY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; EOSINOPHILIA; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INFECTIOUS COMPLICATION; LEUKOCYTE; LYMPHADENOPATHY; LYMPHOPROLIFERATIVE DISEASE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; REVIEW; SPLENOMEGALY;

ANTIBODIES; ANTIGENS, CD95; APOPTOSIS; AUTOIMMUNE DISEASES; BIOPSY; CELLS, CULTURED; CYTOKINES; EOSINOPHILIA; EOSINOPHILS; FEMALE; HUMANS; LEUKOCYTE COUNT; LYMPHOPROLIFERATIVE DISORDERS; MALE; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES;

EID: 34347356402     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20851     Document Type: Review

References (27)

1. Sneller MC, Dale JK, Straus SE. Autoimmune lymphoproliferative syndrome. Curr Opin Rheumatol 2003;15:417-421.
2. Maric I, Pittaluga S, Dale JK, et al. Histologic features of sinus histiocytosis with massive lymphadenopathy in patients with autoimmune lymphoproliferative syndrome. Am J Surg Pathol 2005;29:903-911.
3. Alvarado CS, Straus SE, Li S, et al. Autoimmune lymphoproliferative syndrome: A cause of chronic splenomegaly, lymphadenopathy, and cytopenias in children-report on diagnosis and management of five patients. Pediatr Blood Cancer 2004;43:164-169.
4. Straus SE, Jaffe ES, Puck JM, et al. The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. Blood 2001;98:194-200.
5. Rieux-Laucat F, Le Deist F, Fischer A. Autoimmune lymphoproliferative syndromes: Genetic defects of apoptosis pathways. Cell Death Differ 2003;10:124-133.
6. Fuss IJ, Strober W, Dale JK, et al. Characteristic T helper 2 T cell cytokine abnormalities in autoimmune lymphoproliferative syndrome, a syndrome marked by defective apoptosis and humoral autoimmunity. J Immunol 1997;158:1912-1918.
7. Lopatin U, Yao X, Williams RK, et al. Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression. Blood 2001;97:3161-3170.
8. Sneller MC, Wang J, Dale JK, et al. Clinical, immunologic and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. Blood 1997;89:1341-1348.
9. Sneller MC, Straus SE, Jaffe ES, et al. A novel lymphoproliferative/ autoimmune syndrome resembling murine Ipr/gld disease. J Clin Invest 1992;90:334-341.
10. Renston JP, Goldman ES, Hsu RM, Tomashefski JF Jr. Peripheral blood eosinophilia in association with sarcoidosis. Mayo Clin Proc 2000;75:586-590.
11. Wright R, Truelove SC. Circulating and tissue eosinophils in ulcerative colitis. Am J Dig Dis 1966;11:831-846.
12. Murata K, Yamada Y, Kamihira S, et al. Frequency of eosinophilia in adult T-cell leukemia/lymphoma. Cancer 1992;69:966-971.
13. Simon HU, Yousefi S, Dommann-Scherrer CC, et al. Expansion of cytokine-producing CD4 CD8 T cells associated with abnormal Fas expression and hypereosinophilia. J Exp Med 1996;183:1071-1082.
14. Simon HU, Plotz SG, Dummer R, Blaser K. Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia. N Engl J Med 1999;341:1112-1120.
15. Roufosse F, Schandene L, Sibille C, et al. Clonal Th2 lymphocytes in patients with the idiopathic hypereosinophilic syndrome. Br J Haematol 2000;109:540-548.
16. Aspinall AI, Pinto A, Auer IA, et al. Identification of new Fas mutations in a patient with autoimmune lymphoproliferative syndrome (ALPS) and eosinophilia. Blood Cells Mol Dis 1999;25: 227-238.
17. Hansel TT, DeVries IJ, Iff T, et al. An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. J Immunol Methods 1991;145:105-110.
18. Kim YJ, Prussin C, Martin B, et al. Rebound eosinophilia after treatment of hypereosinophilic syndrome and eosinophilic gastroenteritis with monoclonal anti-IL-5 antibody SCH55700. J Allergy Clin Immunol 2004;114:1449-1455.
19. Gleich GJ. Mechanisms of eosinophil-associated inflammation*1. J Allergy Clin Immunol 2000;105:651-663.
20. Kwon SW, Procter J, Dale JK, Straus SE, Stroncek DF. Neutrophil and platelet antibodies in autoimmune lymphoproliferative syndrome. Vox Sang 2003;85:307-312.
21. Hesse M, Piccirillo CA, Belkaid Y, et al. The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells. J Immunol 2004;172: 3157-3166.
22. Schandene L, Alonso-Bega C, Willems F, et al. B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10. J Immunol 1994;152:4368-4374.
23. Stroncek DF, Carter LB, Procter JL, Dale JK, Straus SE. RBC autoantibodies in autoimmune lymphoproliferative syndrome. Transfusion 2001;41:18-23.
24. Rosenthal D, LeBoit PE, Klumpp L, Berger TG. Human immunodeficiency virus-associated eosinophilic folliculitis. A unique dermatosis associated with advanced human immunodeficiency virus infection. Arch Dermatol 1991;127:206-209.
25. Hayes BB, Hille RC, Goldberg LJ. Eosinophilic folliculitis in 2 HIV-positive women. Arch Dermatol 2004;140:463-465.
26. Matsushima T, Handa H, Yokohama A, et al. Prevalence and clinical characteristics of myelodysplastic syndrome with bone marrow eosinophilia or basophilia. Blood 2003;101: 3386-3390.
27. Tancrede-Bohin E, Ionescu MA, delaSalmoniere P, et al. Prognostic value of blood eosinophilia in primary cutaneous T-cell lymphomas. Arch Dermatol 2004;140:1057-1061.